- Home
- REFI vs CLPT Comparison
REFI vs CLPT Comparison
Compare REFI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- CLPT
- Stock Information
- Founded
- REFI 2021
- CLPT 1998
- Country
- REFI United States
- CLPT United States
- Employees
- REFI N/A
- CLPT N/A
- Industry
- REFI Real Estate Investment Trusts
- CLPT Medical/Dental Instruments
- Sector
- REFI Real Estate
- CLPT Health Care
- Exchange
- REFI Nasdaq
- CLPT Nasdaq
- Market Cap
- REFI 283.7M
- CLPT 318.4M
- IPO Year
- REFI 2021
- CLPT N/A
- Fundamental
- Price
- REFI $12.64
- CLPT $29.60
- Analyst Decision
- REFI Strong Buy
- CLPT Strong Buy
- Analyst Count
- REFI 3
- CLPT 3
- Target Price
- REFI $20.00
- CLPT $27.67
- AVG Volume (30 Days)
- REFI 146.3K
- CLPT 1.6M
- Earning Date
- REFI 11-06-2025
- CLPT 11-06-2025
- Dividend Yield
- REFI 16.32%
- CLPT N/A
- EPS Growth
- REFI N/A
- CLPT N/A
- EPS
- REFI 1.84
- CLPT N/A
- Revenue
- REFI $56,608,781.00
- CLPT $33,593,000.00
- Revenue This Year
- REFI $11.43
- CLPT $22.34
- Revenue Next Year
- REFI $4.75
- CLPT $25.50
- P/E Ratio
- REFI $6.87
- CLPT N/A
- Revenue Growth
- REFI 2.58
- CLPT 19.68
- 52 Week Low
- REFI $12.33
- CLPT $9.76
- 52 Week High
- REFI $16.29
- CLPT $29.80
- Technical
- Relative Strength Index (RSI)
- REFI 32.58
- CLPT 81.01
- Support Level
- REFI $12.51
- CLPT $24.21
- Resistance Level
- REFI $12.97
- CLPT $28.73
- Average True Range (ATR)
- REFI 0.27
- CLPT 2.11
- MACD
- REFI -0.05
- CLPT 0.93
- Stochastic Oscillator
- REFI 16.73
- CLPT 84.70
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.